BackEvoke Pharma Overview

Evoke Pharma Selling, General & Admin

Selling, General & Admin expenses for EVOK.

Quarterly SG&A Expenses

$5.31M
↑ 38.97% YoY

As of Sep 30, 2025

Annual SG&A Expenses (TTM)

$19.13M
↑ 34.92% YoY

Trailing 12 months ending Sep 30, 2025

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin